Skin cancer surgery pain showdown: four numbing drugs compared in major trial
NCT ID NCT07601750
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests four different numbing medicines (lidocaine, bupivacaine, chlorprocaine, and mepivacaine) to see which one causes the least pain when re-injected during Mohs skin cancer surgery. About 400 adults having Mohs surgery will rate their pain on a 1-10 scale. The goal is to find the most comfortable option for patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA, LOCAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor University Medical Center
Dallas, Texas, 75246, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could kids have upper limb surgery fully awake? new trial tests the idea
- AI predicts dental numbing success in painful tooth condition
- New radiation implant shows promise for skin cancer
- New painkiller aims to replace opioids after skin cancer surgery
- Hip fracture pain study halted early – results uncertain
- New pain block technique tested for heart surgery recovery